Gaingels

Founded in 2014, Gaingels is a venture investment syndicate dedicated to supporting the LGBT+ community. It invests globally in companies led by LGBT+ founders or C-suite executives at all stages of growth, focusing on inclusivity and positive social change.

Marc Baum

Investor

David Beatty

Managing Partner

Jesse Curran

Principal

Paul Grossinger

Investor

Todd Havill

Research Operations and Principal, Investment

Surya Jayaweera

Angel Investor

Jennifer Jeronimo

CEO and General Partner

Jake Prigoff MD

General Partner

Peter Steinberg

General Partner

Alexandra Tanner

Investor

Lorenzo Thione

Managing Director

Past deals in Healthcare

Cofertility

Series A in 2025
Cofertility is a human-centered fertility ecosystem that offers egg donation and egg-freezing services for fertility care and third-party reproduction. The platform connects women who wish to store eggs with families unable to conceive, providing a scalable model for egg donation and enabling free egg freezing when donors donate half of their eggs to another family. By matching candidates with donors, coordinating freezing and donation, Cofertility supports individuals and families throughout the fertility journey and aims to improve access to family-building options.

Ignota Labs

Seed Round in 2025
Ignota Labs is a pioneering medical technology company focused on enhancing the drug discovery process through advanced artificial intelligence methods. By utilizing deep learning and machine learning algorithms, the company aims to analyze complex molecular data to predict toxicity early in the development of pharmaceuticals. This proactive approach helps to identify harmful compounds, thereby minimizing environmental impact and waste. Ignota Labs' innovative platform not only streamlines the drug discovery process but also enhances drug safety, ultimately facilitating the timely introduction of life-changing medications to the market.

Afynia Laboratories

Seed Round in 2025
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.

Qnovia

Series B in 2024
Qnovia is a biotechnology company specializing in aerosol science. It develops innovative devices and formulations for safely delivering a wide range of pharmaceuticals and nicotine via inhalation. The company aims to enhance public health by creating efficient medical devices, responsibly sourcing materials, advocating for legislation, providing transparent product information, and promoting sensible oversight.

Arda Therapeutics

Series A in 2024
Founded in 2021, Arda Therapeutics is a biotechnology company based in the San Francisco Bay Area. It specializes in developing transformative therapeutics to eliminate pathogenic cells that drive chronic diseases and aging.

Afynia Laboratories

Seed Round in 2024
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.

Grayce

Series A in 2024
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.

OverT Bio

Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the obstacles posed by tumors. Through its innovative approach, OverT Bio aims to enhance the effectiveness and durability of immunotherapies, contributing to advancements in cancer identification and treatment within the healthcare sector.

Testmate Health

Seed Round in 2024
Testmate Health is a medtech startup and award-winning spin-off of the University of Geneva in Switzerland. It has developed a smartphone-compatible platform test kit capable of diagnosing diseases based on identifiable DNA or RNA sequences without the need for a laboratory, delivering results in minutes at home. The initial product is a rapid urine self-test for the four most common sexually transmitted infections, designed to be used outside clinical settings and to provide a smartphone-scanable result that supports immediate access to treatment if needed. The platform uses DNA isothermal technology to detect infectious diseases with identifiable DNA, enabling home testing without laboratory submission. Further test kits for additional diseases are in development to empower users to monitor their health from home.

Limbic

Series A in 2024
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

Ezra AI

Series B in 2024
Ezra AI, Inc. is a company focused on developing artificial intelligence technology to enhance cancer detection through investigational devices. Established in 2017 and headquartered in New York, it has pioneered a novel approach to cancer screening utilizing full-body MRI technology supported by AI. The company's initial product is an FDA-cleared software designed to assist radiologists in interpreting MRI images specifically for prostate cancer. Ezra AI primarily serves customers in New York and California, aiming to improve early cancer detection and diagnosis through its innovative solutions.

Hone Health

Venture Round in 2024
Hone Health is a digital health platform specializing in men's wellness. It provides personalized care, including licensed physician consultations, data-driven insights, and prescription medications.

Shimmer

Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

BetterBrand

Venture Round in 2024
BetterBrand is a food technology company focused on nutrition innovation in the refined carbohydrate category. Its flagship product, The Better Bagel, reimagines a carb-heavy bagel by delivering net carbohydrates equivalent to two slices of banana while adding more than 25 grams of plant-based protein, with no added sugar and a clean, Non-GMO verified ingredient deck. The company aims to empower consumers to enjoy familiar foods without guilt by combining taste, nutrition, and simple ingredients. Through its products, BetterBrand seeks to shift eating patterns toward better health and sustained wellbeing, supporting productivity and quality of life. The business emphasizes transparent sourcing and a clean-label approach, appealing to health-conscious shoppers seeking convenient, nourishing options in the everyday diet.

Seismic Therapeutic

Series B in 2023
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.

Pair Team

Series A in 2023
Pair Team provides healthcare coordination services focused on underserved and vulnerable communities. It deploys a dedicated, tech-enabled care team—including community health workers, registered nurses, and behavioral health clinicians—to offer personalized, holistic support to Medicaid and Medicare patients and other low-income individuals facing barriers to care such as transportation, housing and food insecurity, and limited mobile access. The company acts as an extension of safety-net primary care systems, helping them deliver patient-centered care while integrating with community-based organizations. It is building a care delivery platform to standardize clinical practices, streamline administrative tasks, and enable clinicians to spend more time with patients.

Allara Health

Series A in 2023
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Atropos Health

Venture Round in 2023
Founded in 2019, Atropos Health specializes in transforming health data into usable real-world evidence. Its platform combines electronic medical record data to derive digital evidence for individual patients, enabling healthcare institutions to create value from previously siloed data and improve clinical outcomes.

Carenostics

Seed Round in 2023
Carenostics is a health technology company that uses artificial intelligence and machine learning to address underdiagnosis, undertreatment, and health inequities in chronic disease care. Its detection models analyze data from routine patient care and integrate with provider electronic health records to identify undiagnosed chronic conditions, project disease progression, and help clinicians prioritize patients for timely intervention.

Remedial Health

Series A in 2023
Remedial Health is a company focused on enhancing the procurement and distribution of pharmaceuticals across Africa. It provides a platform that facilitates business-to-business access to medicines, enabling pharmacies and hospitals to order and access retail medications directly from manufacturers or distributors. This approach addresses the inefficiencies and risks associated with relying on open-air medicine markets, where healthcare providers often encounter counterfeit products. By improving the pharmacy operations and workflow management processes, Remedial Health aims to ensure that healthcare providers can more effectively stock their facilities, thereby contributing to a safer and more reliable healthcare environment.

ReflexAI

Seed Round in 2023
ReflexAI empowers human support teams by providing scalable AI tools for advanced roleplay simulations and intelligent quality assurance, enhancing outcomes in every customer interaction.

Alnair Therapeutics

Pre Seed Round in 2023
Alnair Therapeutics is a preclinical stage company specializing in precision oncology, dedicated to developing innovative solutions for challenging malignancies. The company has pioneered a unique drug delivery technology that harnesses the distinctive characteristics of cancer metabolism to enhance the targeting and penetration of therapeutic agents directly into cancer cells. This approach aims to improve treatment outcomes for patients suffering from difficult-to-treat cancers, addressing a significant need in the oncology field.

BetterBrand

Series A in 2023
BetterBrand is a food technology company focused on nutrition innovation in the refined carbohydrate category. Its flagship product, The Better Bagel, reimagines a carb-heavy bagel by delivering net carbohydrates equivalent to two slices of banana while adding more than 25 grams of plant-based protein, with no added sugar and a clean, Non-GMO verified ingredient deck. The company aims to empower consumers to enjoy familiar foods without guilt by combining taste, nutrition, and simple ingredients. Through its products, BetterBrand seeks to shift eating patterns toward better health and sustained wellbeing, supporting productivity and quality of life. The business emphasizes transparent sourcing and a clean-label approach, appealing to health-conscious shoppers seeking convenient, nourishing options in the everyday diet.

Every Health

Pre Seed Round in 2023
Tech-enabled healthcare solution for the underserved LGBTQIA+ community.

Movo

Venture Round in 2023
Movo is a workforce management platform for frontline workers that provides real-time visibility for supervisors and enables large-scale deployments. It combines human capital management with AI-powered features in a mobile-first solution, delivering credentialed professionals and end-to-end software across healthcare, clean energy, manufacturing, and field engineering. The platform helps organizations deploy, credential, and coordinate field staff efficiently, enabling supervisors to handle higher task volumes and manage extensive teams.

Aether Bio

Venture Round in 2023
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Galileo

Venture Round in 2023
Galileo is a technology company based in New York, founded in 2014, specializing in healthcare solutions. The company offers a mobile application and online communication platform that enables medical professionals to provide comprehensive clinical care directly from their phones. This includes synchronous and asynchronous telecommunications technologies for connecting providers with patients. Galileo's services cater to diverse patient populations, offering high-touch, data-driven, multi-specialty longitudinal care over the phone, at home, and in various settings. The company is recognized by regional and national health plans, employers, and Fortune 500 companies as a leading solution for improving population health.

SpecCheck

Seed Round in 2023
SpecCheck is an optical platform designed to enhance the efficiency of eye care specialists. It offers an all-in-one solution that facilitates accurate prescription eyewear ordering and tracking, seamless billing, and improved communication among patients, eye doctors, and lab partners. By optimizing these processes, SpecCheck enables users to work more efficiently and reduce costly errors, ultimately increasing productivity and enhancing overall workflow within the eye care industry.

SoundMind

Seed Round in 2023
SoundMind is a mental health platform that provides personalized music therapy to support stress, anxiety, and trauma management, with a focus on students and marginalized communities. The service combines audio and visual therapy tailored to individual needs to improve mood and promote relaxation, helping users care for their mental health through music. It operates as an Ed-Tech solution and offers data-driven tools for organizations to monitor members' overall wellness and deliver reset and refocus moments. Founded in 2020 and based in Los Angeles, SoundMind aims to make music therapy accessible and actionable for a broad audience, leveraging technology to enhance well-being in educational and community settings.

Previse

Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.

Wave Life

Seed Round in 2023
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.

Healium

Seed Round in 2023
Healium is a technology company that develops mental fitness tools and immersive, bio-data-driven experiences to support self-management of anxiety, sleep issues, burnout, and overall well-being. The platform links real-time biometric data from wearables such as heart rate and brain activity via EEG headbands to personalized video or VR assets, producing reactive media escapes controlled by the user’s physiology. By integrating wearable devices and sensors, Healium delivers data-driven content that adapts to the user in real time, aiming to reduce anxiety, improve mood, and build resilience for individuals and organizations. Peer-reviewed studies have reported rapid mood benefits and anxiety reduction in as little as four minutes.

Journey Clinical

Series A in 2023
Journey Clinical offers an online platform that supports independent psychotherapists in expanding their practices to include ketamine-assisted psychotherapy. The company facilitates prescription services, enabling mental health professionals to provide safe and effective psychedelic therapy to patients.

ImmuneBridge

Venture Round in 2023
ImmuneBridge develops allogeneic immunotherapies for cancer treatment. Its key innovation involves creating immune stem cells from cord blood, providing a fresh, adaptable, reliable, and abundant cellular source for immunotherapies.

One Body

Seed Round in 2023
One Body develops automation and machine learning software tailored for physical therapy clinics. Their platform streamlines healthcare insurance verification processes, saving providers time and money while increasing claim approval rates.

Juno Medical

Series A in 2022
Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Yes Hearing

Series A in 2022
Yes Hearing is a New York-based company that sells hearing aid devices and accessories and improves access to hearing healthcare. The company offers a range of hearing devices and supports a care model that combines tele-audiology with in-home audiologist visits, enabling remote care and in-person services through home visits. The platform aims to help seniors manage hearing loss by connecting them with hearing technology and professional support via home delivery and remote consultations. Founded in 2020 by Sam Shear and Oliver Philips, Yes Hearing emphasizes convenient access to hearing care for the elderly.

Gabbi

Seed Round in 2022
Gabbi is a healthcare technology company that uses AI and clinical research to help women understand and proactively manage their health risks, with a focus on breast cancer risk, prevention, and early detection. The platform offers a lifetime risk assessment, personalized action plans, and virtual care options such as video appointments and chat, along with a community network that supports ongoing engagement and informed decision making.

Shimmer

Seed Round in 2022
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

Qnovia

Series A in 2022
Qnovia is a biotechnology company specializing in aerosol science. It develops innovative devices and formulations for safely delivering a wide range of pharmaceuticals and nicotine via inhalation. The company aims to enhance public health by creating efficient medical devices, responsibly sourcing materials, advocating for legislation, providing transparent product information, and promoting sensible oversight.

Gameto

Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Uplift Labs

Seed Round in 2022
Uplift Labs is a Palo Alto-based company that develops AI-powered motion analysis technology to help people move better and reduce injuries. Its platform provides in-depth kinematic analyses to assess movement performance across sports, fitness, and everyday life. Using proprietary deep learning models, the system analyzes movement to support performance improvements for professional teams, healthcare organizations, and individuals. The company translates complex movement data into actionable insights for training, rehab, and injury prevention, enabling users to optimize technique and reduce risk.

Disclo

Pre Seed Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Cartography Biosciences

Series A in 2022
Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform focused on sexual care and performance health, catering to both men and women. The company offers comprehensive solutions for sperm health and sexual performance in men, as well as addressing issues such as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, such as semen analyses and PCOS assessments, along with telehealth consultations and supplements. Additionally, Kindly Health has developed an AI and computer vision tool aimed at improving the embryo selection process in fertility treatments, thereby increasing the success rate of in vitro fertilization (IVF). Through these innovations, Kindly Health strives to make fertility care and sexual health solutions more affordable and accessible for patients.

Choiz

Seed Round in 2022
Choiz is a healthcare platform that provides a personalized, end-to-end care experience delivered directly to patients at home. It covers diagnosis, prescription and delivery of medications, and ongoing remote care managed by health professionals. The platform aims to expand access to specialized treatments, including programs for hair growth, skincare, and weight loss, with regular medication supplies and continuous support without requiring in-person visits.

STRIVE

Series A in 2022
STRIVE provides a platform that uses sensors in compression shorts to gather muscle movement data via surface electromyography (sEMG) and accelerometers. This data helps athletes, military personnel, and industrial workers track muscle activity, monitor fatigue, prevent injuries, and enhance performance.

Boulder Care

Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

MindRight Health

Seed Round in 2022
MindRight Health, Inc. is a Newark, New Jersey-based company founded in 2019 that offers mental health coaching via text messaging. Its mission is to promote health equity by providing accessible and inclusive mental health care, particularly for communities of color and low-income families. MindRight partners with healthcare payers and providers to deliver culturally responsive coaching, assigning users to personal coaches who offer support year-round. This approach aims to create a continuum of care that addresses the unique needs of youth and communities that often avoid traditional clinical services due to stigma and limited access. Additionally, MindRight provides its partners with real-time data on community mental health needs, which helps in predicting and preventing mental health crises.

Torigen Pharmaceuticals

Venture Round in 2022
Founded in 2013, Torigen Pharmaceuticals specializes in developing innovative cancer care solutions for pets. Based in Farmington, Connecticut, the company focuses on advancing scientific research to bring novel approaches to companion animal cancers.

OYE

Pre Seed Round in 2022
OYE is a wellness app focused on enhancing emotional well-being through mind-body practices and community engagement. The platform offers daily emotional check-ins, personalized goal setting, and mindful notifications to help users transform their emotions into creative actions. Available in both Spanish and English, OYE provides guided reflections and expressive movement practices aimed at shifting moods and improving interpersonal relationships. By fostering a supportive environment, OYE enables members of the Latino community to enhance their mental health, experience personal growth, and build connections regardless of their location.

Adni

Seed Round in 2022
Adni streamlines career management for healthcare professionals via a single AI-powered app. It offers job matching, resource purchasing, credential updates, networking, and daily education. For employers, Adni facilitates recruitment and retention through a white-labeled gamified intranet.

Curebase

Series B in 2022
Curebase is a company that specializes in developing software for clinical trials, aimed at enhancing the efficiency of the clinical research process. Founded in 2017 and based in San Francisco, California, Curebase offers a digital clinical trial assistant that transforms how medical providers discover, activate, and manage clinical trials for patients. The platform reduces recruitment times and automates various manual processes, allowing drug companies to distribute their trials more effectively to clinics. Additionally, it provides comprehensive data access for sponsors, enabling real-time monitoring of trial progress and data management. Curebase serves a diverse clientele, including medical device, biotech, and digital health startups, with a focus on enabling virtual studies and streamlining participant eligibility, enrollment, education, and consent.

Nelly

Seed Round in 2022
Nelly provides a tool for medical practices that digitizes patient onboarding, signatures, and payments to reduce administrative workload. The solution collects patient data via a mobile intake, enables secure e-signatures, and offers flexible payment options. It also allows documents and patient data to be transferred to a practice management system and supports sending treatment contracts by SMS or email for signature. By simplifying documentation and payments, Nelly aims to make clinic visits more efficient for both patients and staff, reducing bureaucratic burdens in healthcare.

Diligent Robotics

Series B in 2022
Diligent Robotics develops hospital service robots and related AI software to assist clinical and nursing staff with logistical tasks, enabling more time for direct patient care. Its flagship robot, Moxi, operates in hospital environments to handle routine duties and collaborate with humans, supported by AI-based software that enables safe interaction and adaptation to human workflows. Founded in 2017 and based in Austin, Texas, the company seeks to improve patient satisfaction, quality of care, and safety by augmenting healthcare teams with robotic assistance.

SoundMind

Pre Seed Round in 2022
SoundMind is a mental health platform that provides personalized music therapy to support stress, anxiety, and trauma management, with a focus on students and marginalized communities. The service combines audio and visual therapy tailored to individual needs to improve mood and promote relaxation, helping users care for their mental health through music. It operates as an Ed-Tech solution and offers data-driven tools for organizations to monitor members' overall wellness and deliver reset and refocus moments. Founded in 2020 and based in Los Angeles, SoundMind aims to make music therapy accessible and actionable for a broad audience, leveraging technology to enhance well-being in educational and community settings.

One Body

Pre Seed Round in 2022
One Body develops automation and machine learning software tailored for physical therapy clinics. Their platform streamlines healthcare insurance verification processes, saving providers time and money while increasing claim approval rates.

Starling Medical

Seed Round in 2022
Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.

Minded

Seed Round in 2022
Minded is an online psychiatry practice specializing in mental health services for women.

Wavely Diagnostics

Seed Round in 2022
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Uplift Labs

Seed Round in 2022
Uplift Labs is a Palo Alto-based company that develops AI-powered motion analysis technology to help people move better and reduce injuries. Its platform provides in-depth kinematic analyses to assess movement performance across sports, fitness, and everyday life. Using proprietary deep learning models, the system analyzes movement to support performance improvements for professional teams, healthcare organizations, and individuals. The company translates complex movement data into actionable insights for training, rehab, and injury prevention, enabling users to optimize technique and reduce risk.

Skippet

Seed Round in 2022
Skippet enables users to create custom digital solutions tailored to their specific problems by simply describing them in plain English. The company's proprietary architecture translates natural language into functional applications or workflows, leveraging existing systems and integrations.

AmorSui

Seed Round in 2022
Founded in 2020, AmorSui is a pioneering company specializing in the design and innovation of medical gowns and lab jackets for healthcare professionals. Their products are antimicrobial, static-resistant, protective against bodily fluids, reusable, and recyclable.amorSui delivers premium quality, comfortable, and eco-friendly PPE made and sourced entirely in the USA.

Sonic Incytes Medical Corp

Series A in 2021
Sonic Incytes Medical Corp develops handheld ultrasound solutions for point-of-care assessment and monitoring of chronic liver diseases. It uses quantitative ultrasound and elastography with artificial intelligence to provide deeper measurements, larger tissue samples, and single-probe operation without recalibrations, enabling guidance for diagnostics and procedures. The devices assess liver stiffness, attenuation, and fat fraction to support diagnosis and management of liver health. The company was incorporated in 2012 and is based in Vancouver, Canada.

Suki

Series C in 2021
Suki develops AI-driven voice solutions for healthcare providers. Its primary product, Suki Assistant, uses artificial intelligence and natural language processing to create detailed clinical notes during or after consultations, enabling physicians to complete administrative tasks more efficiently.

Limbix

Series A in 2021
Limbix is a company dedicated to developing prescription digital therapeutics for adolescent mental health. Their flagship product, SparkRx, is an evidence-based, clinically validated tool designed to treat depression and anxiety in teenagers. Limbix combines clinical expertise with technological innovation to deliver effective mental health treatments.

CareAlign

Seed Round in 2021
CareAlign is a developer of a real-time data system that enhances the management and coordination of clinical care for clinicians. The company offers an intuitive, patient-centric task management tool that allows healthcare professionals to assign tasks, set deadlines, and categorize them based on urgency. By aggregating data from multiple sources, CareAlign provides a comprehensive and clinically intuitive display of patients' clinical status, facilitating better understanding and decision-making in patient care. This system aims to streamline workflows and improve communication among clinicians, ultimately enhancing the quality of care delivered to patients.

OxiWear

Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices specifically designed for continuous oxygen monitoring and emergency alerting, targeting patients prone to silent hypoxia due to conditions such as pulmonary hypertension, high-altitude environments, high-intensity cardio activities, and COVID-19. The company's patented pulse oximeter offers a novel approach to monitoring oxygen levels, facilitating use in both clinical and consumer settings. By providing real-time data and alerts, OxiWear's technology enhances patient safety and peace of mind, ensuring timely medical assistance when needed.

Valera Health

Venture Round in 2021
Valera Health, founded in 2015, operates a behavioral healthcare platform that integrates digital technology and data science with personalized clinical services. The company focuses on delivering comprehensive mental health care to individuals experiencing a range of conditions, from mild issues like depression to more severe disorders such as schizophrenia. By combining therapy and medication with advanced technology, Valera Health aims to provide efficient access to mental health services, particularly for hard-to-reach populations. This approach not only enhances patient outcomes but also facilitates continuous connectivity between patients and their care teams, thereby redefining the standards of high-performing mental healthcare.

Ruth Health

Seed Round in 2021
Ruth Health is a telehealth provider specializing in women's health and prenatal care. They empower parents through evidence-based expertise, enhancing accessibility and affordability of childbirth services.

Aether Bio

Seed Round in 2021
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Zeit Medical

Seed Round in 2021
Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.

BIOMILQ

Series A in 2021
BIOMILQ develops lab-grown human milk ingredients from cultured mammary cells to support infant nutrition. Founded in 2020 and based in Durham, North Carolina, the company is women-owned and science-led, building a mammary biomanufacturing platform to produce bioauthentic human milk ingredients for early-life nutrition. The platform combines human mammary cells with a scalable manufacturing process to create milk ingredients that promote gut, immune, and brain development, offering families a nutritious and sustainable option for feeding babies.

Options MD

Pre Seed Round in 2021
Options MD is a telemedicine platform that employs AI-driven algorithms to match individuals with severe or treatment-resistant mental illnesses to personalized care options. It then connects these patients with in-house psychiatric experts for appropriate medical assistance.

Sonavi Labs

Seed Round in 2021
Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

Eleos Health

Seed Round in 2021
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.

Movo

Funding Round in 2021
Movo is a workforce management platform for frontline workers that provides real-time visibility for supervisors and enables large-scale deployments. It combines human capital management with AI-powered features in a mobile-first solution, delivering credentialed professionals and end-to-end software across healthcare, clean energy, manufacturing, and field engineering. The platform helps organizations deploy, credential, and coordinate field staff efficiently, enabling supervisors to handle higher task volumes and manage extensive teams.

Kenshō Health

Seed Round in 2021
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Crescent Health

Pre Seed Round in 2021
Crescent Health is working to make sleep health accessible to all. It hastens the development of individual health, beginning with sleep. They are employed by meet sleep coach. Connecting a sleep monitor to an app get monthly customized sleep plans, track sleep health, and find the ideal schedule.

Ruth Health

Pre Seed Round in 2021
Ruth Health is a telehealth provider specializing in women's health and prenatal care. They empower parents through evidence-based expertise, enhancing accessibility and affordability of childbirth services.

Brightline

Series B in 2021
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Protenus

Series D in 2021
Protenus, Inc. is a healthcare compliance analytics company based in Baltimore, Maryland, which was founded in 2014. The company specializes in an AI-driven platform designed to audit access to patient records across health systems in the United States. Protenus' technology identifies risks such as inappropriate access to patient data and the misuse of controlled substances by healthcare staff. By automating the detection of policy violations and other anomalous behaviors, the platform supports healthcare organizations in protecting patient privacy and reducing operational risks. Protenus is recognized for its innovation and commitment to fostering safe patient outcomes while enhancing the reputation of healthcare providers. The company has received accolades such as being named one of America's Best Startup Employers by Forbes and recognized as a Great Place to Work.

Silver Bills

Seed Round in 2021
SilverBills specializes in bill-paying technology aimed at alleviating the burden of managing bills for seniors. The company offers a service that receives clients' bills electronically, carefully reviews them, and processes payments using secure technology. This system is designed to simplify daily financial management, allowing elderly Americans and their families to maintain their independence and live comfortably in their homes. SilverBills charges a straightforward, flat monthly fee for its services, thereby reducing the stress and anxiety often associated with bill payments.

Ever/Body

Series B in 2021
Ever/Body is a New York-based provider of dermatology and cosmetic treatments, focusing on demystifying the field of cosmetic dermatology. The company offers a range of services, including injectable treatments, high-tech facials, and non-surgical body treatments. These medically-tested procedures are designed to deliver optimal results, such as reducing wrinkles and enhancing overall appearance, allowing clients to achieve a more youthful and rejuvenated look. By prioritizing client preferences, Ever/Body aims to make beauty and cosmetic care accessible and effective.

Gilgamesh Pharmaceuticals

Series A in 2021
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, focused on developing innovative psychotropic drugs to address mental health issues. Founded in 2019, the company specializes in creating novel compounds that enhance the benefits of traditional psychedelics, improving parameters such as safety, tolerability, duration, and efficacy. Gilgamesh targets a range of neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. With the growing global mental health crisis, the company aims to accelerate the development of new treatments that meet the urgent need for effective solutions in mental health care, leveraging its expertise in medicinal chemistry and drug development.

CareRev

Series A in 2021
CareRev is an online marketplace connecting hospitals and outpatient facilities directly with per diem medical staff. It eliminates intermediaries, filling empty shifts swiftly, reducing staffing costs, and enhancing patient care quality.

American Gene Technologies International

Venture Round in 2021
American Gene Technologies International is a gene and cell therapeutics company developing a lentiviral platform for broad applications across infectious diseases, immuno-oncology, monogenic disorders, and regenerative medicine. It pursues HIV cure strategies, including a lead candidate for functional cure, and an immuno-oncology approach that stimulates gamma-delta T cells to target solid tumors. The company also develops a therapeutic approach for Phenylketonuria by expressing phenylalanine hydroxylase, using proprietary viral vector and gene therapy technologies. Founded in 2007 and based in Rockville, Maryland, AGT focuses on translating its platform into therapies that aim to cure diseases rather than merely treat them.

Territory Foods

Series B in 2021
Founded in 2011, Territory Foods is a chef-prepared meal delivery service based in Arlington, VA. It offers personalized, nutritionist-approved menus featuring fresh, healthy meals tailored to various dietary preferences and regional tastes. Its rotating menus are responsibly sourced, free of refined sugars, gluten, and dairy, and can be customized to meet specific dietary templates like Vegan, Vegetarian, Whole30, and Keto.

Cleo

Series C in 2021
Cleo Labs, Inc. is a family support platform that offers pregnancy consultancy and parenthood guidance services to working parents. The company provides a range of consultation services, including lactation support, birth preparation, child wellness, and sleep consulting, as well as career coaching and immediate post-birth assistance. Cleo's mobile application connects families with certified care practitioners, facilitating their journey from fertility through parenting children up to age five. By partnering with employers, Cleo aims to enhance workplace culture, improve employee retention, and foster diverse and inclusive environments. The company operates globally, serving clients in over 50 countries and has collaborated with notable organizations such as eBay and LinkedIn. Founded in 2016 and headquartered in San Francisco, Cleo was previously known as Instacare Group, Inc. before rebranding in 2018.

BrightInsight

Series C in 2021
BrightInsight operates a digital health platform tailored for biopharma and medtech companies. Founded in 2017 and headquartered in San Jose, California, the company provides an Internet of Things (IoT) solution designed to support the development, scaling, and maintenance of regulated digital health products and services. The BrightInsight platform captures, transmits, and analyzes data from various sources, including medical devices, combination products, applications, and digital therapeutics, all while adhering to security, privacy, and regulatory standards. This integrated approach enables clients to enhance patient adherence and engagement, accelerate market entry, and reduce implementation costs across diverse products and global markets.

Breathwrk

Seed Round in 2021
Breathwrk develops a mobile application offering science-backed guided breathing exercises. Users can manage mental wellness by reducing anxiety, improving sleep, enhancing focus, and boosting energy.

ELANZA Wellness

Pre Seed Round in 2021
ELANZA Wellness operates a virtual chronic care platform focused on supporting individuals with reproductive health conditions, initially targeting endometriosis. The platform provides personalized treatment plans, access to medical specialists, and evidence-based therapies, aiming to improve symptom-free days.

Harmonize

Series A in 2021
Harmonize is a company that specializes in a remote care platform aimed at enhancing the management of high-risk patients, particularly those who may struggle with technology and have multiple health conditions. Founded in 2019 and headquartered in San Mateo, California, Harmonize's platform streamlines technology implementation and clinical triage, enabling healthcare organizations to provide effective remote care. The interface is designed to accommodate both high-tech and high-touch inputs, facilitating improved patient engagement and adherence rates. By guiding healthcare staff through triage and intervention processes at scale, Harmonize significantly reduces operational overhead while promoting better patient outcomes and lowering healthcare costs.

Feel Therapeutics

Seed Round in 2021
Feel Therapeutics is a digital health company specializing in precision medicine for mental health. It develops physiological and digital biomarkers using advanced computer science methods, leveraging wearable devices to collect and analyze biometric data.

Fuzzy

Series B in 2021
Fuzzy, established in 2016 and headquartered in San Francisco, is a pet healthcare startup offering subscription-based services. It aims to make pet care accessible, affordable, and convenient. Through its mobile application, Fuzzy provides 24/7 veterinary consultations via chat and video. Additionally, it offers home delivery of pet essentials such as medications, supplements, and food for dogs and cats. The company's mission is to cater to the personalized needs of pets, allowing owners to manage their pets' health from home. Notable investors include Precursor Ventures, Eniac Ventures, and Matrix Partners.

Kenshō Health

Venture Round in 2021
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.

Plume Clinic

Series A in 2021
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.

FULLFILL

Seed Round in 2021
FULLFILL is a digital platform offering virtual health coaching programs designed to prevent and treat chronic conditions. It partners with employers worldwide to improve employee health and reduce medical expenses. The platform offers evidence-based content, daily support from Master Coaches, and engages employees effectively, doubling medical results compared to traditional programs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.